- Home
- PTN vs MDCX Comparison
PTN vs MDCX Comparison
Compare PTN & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTN
- MDCX
- Stock Information
- Founded
- PTN 1986
- MDCX 2008
- Country
- PTN United States
- MDCX Canada
- Employees
- PTN N/A
- MDCX N/A
- Industry
- PTN Biotechnology: Pharmaceutical Preparations
- MDCX
- Sector
- PTN Health Care
- MDCX
- Exchange
- PTN Nasdaq
- MDCX Nasdaq
- Market Cap
- PTN 25.4M
- MDCX 29.7M
- IPO Year
- PTN 1993
- MDCX N/A
- Fundamental
- Price
- PTN $1.06
- MDCX $2.99
- Analyst Decision
- PTN Strong Buy
- MDCX Strong Buy
- Analyst Count
- PTN 1
- MDCX 1
- Target Price
- PTN $17.00
- MDCX $10.00
- AVG Volume (30 Days)
- PTN 570.9K
- MDCX 14.9K
- Earning Date
- PTN 02-13-2025
- MDCX 01-01-0001
- Dividend Yield
- PTN N/A
- MDCX N/A
- EPS Growth
- PTN N/A
- MDCX N/A
- EPS
- PTN N/A
- MDCX N/A
- Revenue
- PTN $2,384,113.00
- MDCX N/A
- Revenue This Year
- PTN N/A
- MDCX N/A
- Revenue Next Year
- PTN N/A
- MDCX N/A
- P/E Ratio
- PTN N/A
- MDCX N/A
- Revenue Growth
- PTN N/A
- MDCX N/A
- 52 Week Low
- PTN $0.68
- MDCX $1.80
- 52 Week High
- PTN $5.65
- MDCX $3.23
- Technical
- Relative Strength Index (RSI)
- PTN 47.60
- MDCX N/A
- Support Level
- PTN $1.06
- MDCX N/A
- Resistance Level
- PTN $1.20
- MDCX N/A
- Average True Range (ATR)
- PTN 0.14
- MDCX 0.00
- MACD
- PTN -0.01
- MDCX 0.00
- Stochastic Oscillator
- PTN 7.14
- MDCX 0.00
About PTN Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.